The weakening and bulging of the aorta is called aortic aneurysm. The bulging can cause a leak that spills blood into the body. It can direct the blood flow away from the organs and tissues, causing severe complications, such as kidney damage, heart attacks, stroke, and even death. Thus, endovascular repair can be done by placing a stent-graft in an aneurysm through a small hole in the blood vessels in the groin area.
Due to the COVID-19 pandemic, the global Endovascular Aneurysm Repair Devices market size is estimated to be worth US$ 2305.7 million in 2021 and is forecast to a readjusted size of US$ 3027 million by 2028 with a CAGR of 3.5% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Endovascular Aneurysm Repair Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Endovascular Aneurysm Repair Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The Americas is expected to dominate the global endovascular aneurysm repair devices market owing to increasing geriatric population, and well-developed healthcare sector.
This report focuses on Endovascular Aneurysm Repair Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Endovascular Aneurysm Repair Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Endovascular Aneurysm Repair Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Percutaneous EVAR
Fenestrated EVAR
Aortic Stents & TAA Grafts
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Boston Scientific
Cardinal Health
Terumo
Cook Medical
W.L. Gore
Getinge Group
Endologix
Cardiatis
CryoLife (Jotec GmbH)
BiFlow Medical
EndoSpan
Lemaitre Vascular